• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Downward trend in mortality rate for antineutrophil cytoplasmic autoantibody-associated vasculitis

byThomas SuandDeepti Shroff Karhade
October 7, 2019
in Chronic Disease, Nephrology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this study of decedents from 1999 to 2017, mortality due to antineutrophil cytoplasmic autoantibody-associated vasculitis (AAV) -related illness was found to have decreased by an average of 1.6% per year.

2. Following stratification, non-Hispanic whites, men, and Midwesterners appeared to be disproportionately affected by AAV, but it remained unclear whether this phenomenon should be attributed to biological or social factors.

Evidence Rating Level: 2 (Good)

Study Rundown: Antineutrophil cytoplasmic autoantibody-associated vasculitides (AAVs) are small vessel diseases that can affect nearly every organ system and are associated with significant morbidity and mortality. Historically, patients have largely relied on immunosuppressive therapy, but the effectiveness of such treatment was unclear as long-term outcomes remained poorer than the general population. This study sought to identify mortality trends of AAV in the United States in the past two decades. Overall, the age-adjusted mortality rate was found to have decreased by an average of 1.6% per year. Data from multiple-cause-of-death records indicated that AAV remained the predominant underlying cause of death (UCOD), underscoring the importance of clinical awareness and continued research & development of novel therapies. The study boasts a large sample size. However, it is limited by potential misreporting of AAV on death certificates that could have skewed results. The absence of similar large-scale stratified studies makes it difficult to validate the findings as well.

Click to read the study, published today in Annals of Internal Medicine

Click to read an accompanying editorial in Annals of Internal Medicine

RELATED REPORTS

Benralizumab noninferior to mepolizumab for eosinophilic granulomatosis with polyangiitis

#VisualAbstract: Benralizumab is noninferior to mepolizumab for treatment of eosinophilic granulomatosis with polyangitis

Long-term use of rituximab associated with lower rates of AAV relapse

Relevant Reading: Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitis

In-Depth [retrospective cohort]: For this study, multiple-cause-of-death records were drawn from the Centers for Disease Control and Prevention’s Wide-ranging Online Data for Epidemiologic Research Data- base from 1999 to 2017. AAV mortality was defined as decedents whose causes of death (primary or secondary) included granulomatosis with polyangiitis, microscopic polyangiitis, or eosinophilic granulomatosis with polyangiitis. Of these, granulomatosis with polyangiitis was the leading cause of death at 85%. In conjunction, these AAVs were by far the most common UCOD (64%), trailed by cardiovascular disease (12%), cancer (6%), and pulmonary disorder (5%). The average age-adjusted mortality rate over this period was 1.86 (95% CI, 1.83 to 1.90) per 1,000,000 persons, with non-Hispanic whites, men, and Midwesterners bearing the brunt. Overall mortality rate abated by an average of 1.6% (CI, 2.6% to 0.7%) per year.

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Antineutrophil cytoplasmic autoantibody-associated vasculitides (AAVs)eosinophilic granulomatosis with polyangiitisGranulomatosis with polyangiitismicroscopic polyangiitis
Previous Post

#VisualAbstract: Excess Antibiotic Treatment Duration and Adverse Events in Patients Hospitalized With Pneumonia

Next Post

Quick Take: Treatment for nicotine use disorder among Medicaid-enrolled adolescents and young adults

RelatedReports

Lirentelimab may be effective for treatment of eosinophilic gastrointestinal disease
Chronic Disease

Benralizumab noninferior to mepolizumab for eosinophilic granulomatosis with polyangiitis

April 4, 2024
StudyGraphics

#VisualAbstract: Benralizumab is noninferior to mepolizumab for treatment of eosinophilic granulomatosis with polyangitis

May 15, 2024
Long-term use of rituximab associated with lower rates of AAV relapse
Chronic Disease

Long-term use of rituximab associated with lower rates of AAV relapse

June 1, 2020
Lung cancer screening may lower motivation for smoking cessation
Chronic Disease

Cigarette smoking and antineutrophil cytoplasmic antibody-associated vasculitis

May 5, 2020
Next Post
Strict tobacco licensing laws linked to reduced adolescent smoking initiation

Quick Take: Treatment for nicotine use disorder among Medicaid-enrolled adolescents and young adults

#VisualAbstract: High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas

#VisualAbstract: High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas

Standardized central line care practices reduce bloodstream infections

Billions of dollars spent on US healthcare labeled wasteful

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Fecal microbiota transplantation may be more effective than vancomycin in treating primary C. difficile infection
  • Frailty scores alone may be poor predictors of intensive care admission or hospital stay duration
  • Anal cancer screening cost-effective for men who have sex with men with human immunodeficiency virus aged above 35 years
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.